Stella (Plevan) Dracheva, Ph.D. - Publications

Affiliations: 
Psychiatry Mount Sinai School of Medicine / Bronx VA Hospital 
Area:
neurobiology and neurochemistry of the brain in health and in mental illness
Website:
https://icahn.mssm.edu/profiles/stella-plevan

42 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Girdhar K, Hoffman GE, Bendl J, Rahman S, Dong P, Liao W, Hauberg ME, Sloofman L, Brown L, Devillers O, Kassim BS, Wiseman JR, Park R, Zharovsky E, Jacobov R, ... ... Dracheva S, et al. Chromatin domain alterations linked to 3D genome organization in a large cohort of schizophrenia and bipolar disorder brains. Nature Neuroscience. PMID 35332326 DOI: 10.1038/s41593-022-01032-6  0.439
2018 Kozlenkov A, Li J, Apontes P, Hurd YL, Byne WM, Koonin EV, Wegner M, Mukamel EA, Dracheva S. A unique role for DNA (hydroxy)methylation in epigenetic regulation of human inhibitory neurons. Science Advances. 4: eaau6190. PMID 30263963 DOI: 10.1126/Sciadv.Aau6190  0.362
2018 Egervari G, Kozlenkov A, Dracheva S, Hurd YL. Molecular windows into the human brain for psychiatric disorders. Molecular Psychiatry. PMID 29955163 DOI: 10.1038/S41380-018-0125-2  0.33
2018 McKenzie AT, Wang M, Hauberg ME, Fullard JF, Kozlenkov A, Keenan A, Hurd YL, Dracheva S, Casaccia P, Roussos P, Zhang B. Brain Cell Type Specific Gene Expression and Co-expression Network Architectures. Scientific Reports. 8: 8868. PMID 29892006 DOI: 10.1038/S41598-018-27293-5  0.337
2017 Ibi D, de la Fuente Revenga M, Kezunovic N, Muguruza C, Saunders JM, Gaitonde SA, Moreno JL, Ijaz MK, Santosh V, Kozlenkov A, Holloway T, Seto J, García-Bea A, Kurita M, Mosley GE, ... Dracheva S, et al. Antipsychotic-induced Hdac2 transcription via NF-κB leads to synaptic and cognitive side effects. Nature Neuroscience. PMID 28783139 DOI: 10.1038/Nn.4616  0.328
2017 Kozlenkov A, Jaffe AE, Timashpolsky A, Apontes P, Rudchenko S, Barbu M, Byne W, Hurd YL, Horvath S, Dracheva S. DNA Methylation Profiling of Human Prefrontal Cortex Neurons in Heroin Users Shows Significant Difference between Genomic Contexts of Hyper- and Hypomethylation and a Younger Epigenetic Age. Genes. 8. PMID 28556790 DOI: 10.3390/Genes8060152  0.359
2017 Li Y, Lucas-Osma AM, Black S, Bandet MV, Stephens MJ, Vavrek R, Sanelli L, Fenrich KK, Di Narzo AF, Dracheva S, Winship IR, Fouad K, Bennett DJ. Pericytes impair capillary blood flow and motor function after chronic spinal cord injury. Nature Medicine. PMID 28459438 DOI: 10.1038/Nm.4331  0.306
2016 Halene TB, Kozlenkov A, Jiang Y, Mitchell AC, Javidfar B, Dincer A, Park R, Wiseman J, Croxson PL, Giannaris EL, Hof PR, Roussos P, Dracheva S, Hemby SE, Akbarian S. NeuN(+) neuronal nuclei in non-human primate prefrontal cortex and subcortical white matter after clozapine exposure. Schizophrenia Research. PMID 26776227 DOI: 10.1016/J.Schres.2015.12.016  0.378
2015 Kozlenkov A, Wang M, Roussos P, Rudchenko S, Barbu M, Bibikova M, Klotzle B, Dwork AJ, Zhang B, Hurd YL, Koonin EV, Wegner M, Dracheva S. Substantial DNA methylation differences between two major neuronal subtypes in human brain. Nucleic Acids Research. PMID 26612861 DOI: 10.1093/Nar/Gkv1304  0.355
2015 Akbarian S, Liu C, Knowles JA, Vaccarino FM, Farnham PJ, Crawford GE, Jaffe AE, Pinto D, Dracheva S, Geschwind DH, Mill J, Nairn AC, Abyzov A, Pochareddy S, Prabhakar S, et al. The PsychENCODE project. Nature Neuroscience. 18: 1707-1712. PMID 26605881 DOI: 10.1038/Nn.4156  0.325
2015 Narzo AF, Kozlenkov A, Ge Y, Zhang B, Sanelli L, May Z, Li Y, Fouad K, Cardozo C, Koonin EV, Bennett DJ, Dracheva S. Decrease of mRNA Editing after Spinal Cord Injury is Caused by Down-regulation of ADAR2 that is Triggered by Inflammatory Response. Scientific Reports. 5: 12615. PMID 26223940 DOI: 10.1038/Srep12615  0.384
2014 Di Narzo AF, Kozlenkov A, Roussos P, Hao K, Hurd Y, Lewis DA, Sibille E, Siever LJ, Koonin E, Dracheva S. A unique gene expression signature associated with serotonin 2C receptor RNA editing in the prefrontal cortex and altered in suicide. Human Molecular Genetics. 23: 4801-13. PMID 24781207 DOI: 10.1093/Hmg/Ddu195  0.482
2014 Kozlenkov A, Roussos P, Timashpolsky A, Barbu M, Rudchenko S, Bibikova M, Klotzle B, Byne W, Lyddon R, Di Narzo AF, Hurd YL, Koonin EV, Dracheva S. Differences in DNA methylation between human neuronal and glial cells are concentrated in enhancers and non-CpG sites. Nucleic Acids Research. 42: 109-27. PMID 24057217 DOI: 10.1093/Nar/Gkt838  0.71
2013 Lyddon R, Dwork AJ, Keddache M, Siever LJ, Dracheva S. Serotonin 2c receptor RNA editing in major depression and suicide. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 14: 590-601. PMID 22404657 DOI: 10.3109/15622975.2011.630406  0.754
2012 Carmel L, Koonin EV, Dracheva S. Dependencies among editing sites in serotonin 2C receptor mRNA. Plos Computational Biology. 8: e1002663. PMID 22969417 DOI: 10.1371/Journal.Pcbi.1002663  0.384
2012 Lyddon R, Navarrett S, Dracheva S. Ionotropic glutamate receptor mRNA editing in the prefrontal cortex: no alterations in schizophrenia or bipolar disorder. Journal of Psychiatry & Neuroscience : Jpn. 37: 267-72. PMID 22469055 DOI: 10.1503/Jpn.110107  0.748
2012 Navarrett S, Collier L, Cardozo C, Dracheva S. Alterations of serotonin 2C and 2A receptors in response to T10 spinal cord transection in rats. Neuroscience Letters. 506: 74-8. PMID 22056918 DOI: 10.1016/J.Neulet.2011.10.052  0.387
2010 Lyddon R, Cuppen E, Haroutunian V, Siever LJ, Dracheva S. No link of serotonin 2C receptor editing to serotonin transporter genotype. Neuroreport. 21: 1080-4. PMID 20948451 DOI: 10.1097/Wnr.0B013E32834052F0  0.735
2010 Kerns D, Vong GS, Barley K, Dracheva S, Katsel P, Casaccia P, Haroutunian V, Byne W. Gene expression abnormalities and oligodendrocyte deficits in the internal capsule in schizophrenia. Schizophrenia Research. 120: 150-8. PMID 20580881 DOI: 10.1016/J.Schres.2010.04.012  0.525
2009 Dracheva S, Lyddon R, Barley K, Marcus SM, Hurd YL, Byne WM. Editing of serotonin 2C receptor mRNA in the prefrontal cortex characterizes high-novelty locomotor response behavioral trait. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 2237-51. PMID 19494808 DOI: 10.1038/Npp.2009.51  0.74
2009 Barley K, Dracheva S, Byne W. Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder. Schizophrenia Research. 112: 54-64. PMID 19447584 DOI: 10.1016/J.Schres.2009.04.019  0.404
2009 Wong K, Lyddon R, Dracheva S. TaqMan-based, real-time quantitative polymerase chain reaction method for RNA editing analysis. Analytical Biochemistry. 390: 173-80. PMID 19371717 DOI: 10.1016/J.Ab.2009.04.011  0.726
2008 Dracheva S, Byne W, Chin B, Haroutunian V. Ionotropic glutamate receptor mRNA expression in the human thalamus: absence of change in schizophrenia. Brain Research. 1214: 23-34. PMID 18462708 DOI: 10.1016/J.Brainres.2008.03.039  0.591
2008 Dracheva S, Chin B, Haroutunian V. Altered serotonin 2C receptor RNA splicing in suicide: association with editing. Neuroreport. 19: 379-82. PMID 18303585 DOI: 10.1097/Wnr.0B013E3282F556D2  0.599
2008 Byne W, Dracheva S, Chin B, Schmeidler JM, Davis KL, Haroutunian V. Schizophrenia and sex associated differences in the expression of neuronal and oligodendrocyte-specific genes in individual thalamic nuclei. Schizophrenia Research. 98: 118-28. PMID 18029146 DOI: 10.1016/J.Schres.2007.09.034  0.564
2008 Dracheva S, Patel N, Woo DA, Marcus SM, Siever LJ, Haroutunian V. Increased serotonin 2C receptor mRNA editing: a possible risk factor for suicide. Molecular Psychiatry. 13: 1001-10. PMID 17848916 DOI: 10.1038/Sj.Mp.4002081  0.596
2007 Haroutunian V, Katsel P, Dracheva S, Stewart DG, Davis KL. Variations in oligodendrocyte-related gene expression across multiple cortical regions: implications for the pathophysiology of schizophrenia. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 10: 565-73. PMID 17291370 DOI: 10.1017/S1461145706007310  0.546
2006 Haroutunian V, Katsel P, Dracheva S, Davis KL. The human homolog of the QKI gene affected in the severe dysmyelination "quaking" mouse phenotype: downregulated in multiple brain regions in schizophrenia. The American Journal of Psychiatry. 163: 1834-7. PMID 17012699 DOI: 10.1176/Ajp.2006.163.10.1834  0.566
2006 Lauriat TL, Dracheva S, Kremerskothen J, Duning K, Haroutunian V, Buxbaum JD, Hyde TM, Kleinman JE, McInnes LA. Characterization of KIAA0513, a novel signaling molecule that interacts with modulators of neuroplasticity, apoptosis, and the cytoskeleton. Brain Research. 1121: 1-11. PMID 17010949 DOI: 10.1016/J.Brainres.2006.08.099  0.537
2006 Lauriat TL, Dracheva S, Chin B, Schmeidler J, McInnes LA, Haroutunian V. Quantitative analysis of glutamate transporter mRNA expression in prefrontal and primary visual cortex in normal and schizophrenic brain. Neuroscience. 137: 843-51. PMID 16297566 DOI: 10.1016/J.Neuroscience.2005.10.003  0.577
2006 Dracheva S, Davis KL, Chin B, Woo DA, Schmeidler J, Haroutunian V. Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients. Neurobiology of Disease. 21: 531-40. PMID 16213148 DOI: 10.1016/J.Nbd.2005.08.012  0.575
2005 Dracheva S, McGurk SR, Haroutunian V. mRNA expression of AMPA receptors and AMPA receptor binding proteins in the cerebral cortex of elderly schizophrenics. Journal of Neuroscience Research. 79: 868-78. PMID 15696539 DOI: 10.1002/Jnr.20423  0.577
2004 Bray NJ, Jehu L, Moskvina V, Buxbaum JD, Dracheva S, Haroutunian V, Williams J, Buckland PR, Owen MJ, O'Donovan MC. Allelic expression of APOE in human brain: effects of epsilon status and promoter haplotypes. Human Molecular Genetics. 13: 2885-92. PMID 15385439 DOI: 10.1093/Hmg/Ddh299  0.498
2004 Bai J, He F, Novikova SI, Undie AS, Dracheva S, Haroutunian V, Lidow MS. Abnormalities in the dopamine system in schizophrenia may lie in altered levels of dopamine receptor-interacting proteins. Biological Psychiatry. 56: 427-40. PMID 15364041 DOI: 10.1016/J.Biopsych.2004.06.022  0.564
2004 Dracheva S, Elhakem SL, McGurk SR, Davis KL, Haroutunian V. GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia. Journal of Neuroscience Research. 76: 581-92. PMID 15114630 DOI: 10.1002/Jnr.20122  0.574
2003 Dracheva S, Elhakem SL, Marcus SM, Siever LJ, McGurk SR, Haroutunian V. RNA editing and alternative splicing of human serotonin 2C receptor in schizophrenia. Journal of Neurochemistry. 87: 1402-12. PMID 14713296 DOI: 10.1046/J.1471-4159.2003.02115.X  0.621
2003 Haroutunian V, Dracheva S, Davis KL. Neurobiology of glutamatergic abnormalities in schizophrenia Clinical Neuroscience Research. 3: 67-76. DOI: 10.1016/S1566-2772(03)00020-3  0.56
2002 Visiers I, Ebersole BJ, Dracheva S, Ballesteros J, Sealfon SC, Weinstein H. Structural motifs as functional microdomains in G-protein-coupled receptors: Energetic considerations in the mechanism of activation of the serotonin 5-HT2A receptor by disruption of the ionic lock of the arginine cage International Journal of Quantum Chemistry. 88: 65-75. DOI: 10.1002/Qua.10078  0.325
2001 Dracheva S, Marras SA, Elhakem SL, Kramer FR, Davis KL, Haroutunian V. N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia. The American Journal of Psychiatry. 158: 1400-10. PMID 11532724 DOI: 10.1176/Appi.Ajp.158.9.1400  0.566
2001 Dracheva S, Haroutunian V. Locomotor behavior of dopamine D1 receptor transgenic/D2 receptor deficient hybrid mice. Brain Research. 905: 142-51. PMID 11423089 DOI: 10.1016/S0006-8993(01)02522-7  0.488
2000 Dracheva S, Haroutunian V, Grandy D, Sealfon S. 230. Characterization of the dopamine D1 receptor transgenic mice Biological Psychiatry. 47: S70. DOI: 10.1016/S0006-3223(00)00494-7  0.465
1999 Dracheva S, Xu M, Kelley KA, Haroutunian V, Holstein GR, Haun S, Silverstein JH, Sealfon SC. Paradoxical locomotor behavior of dopamine D1 receptor transgenic mice. Experimental Neurology. 157: 169-79. PMID 10222120 DOI: 10.1006/Exnr.1999.7037  0.499
Show low-probability matches.